Published in Ann Emerg Med on August 01, 1996
Routine opt-out HIV testing in an urban community health center. AIDS Patient Care STDS (2009) 1.74
Nomenclature and definitions for emergency department human immunodeficiency virus (HIV) testing: report from the 2007 conference of the National Emergency Department HIV Testing Consortium. Acad Emerg Med (2008) 1.62
Emergency department patient acceptance of opt-in, universal, rapid HIV screening. Public Health Rep (2009) 1.54
High-volume rapid HIV testing in an urban emergency department. AIDS Patient Care STDS (2009) 1.49
The impact of New York City's 1975 fiscal crisis on the tuberculosis, HIV, and homicide syndemic. Am J Public Health (2006) 1.39
Interpreting and implementing the 2006 CDC recommendations for HIV testing in health-care settings. Public Health Rep (2007) 1.20
PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep (2013) 1.17
Emergency department patient perceptions and preferences on opt-in rapid HIV screening program components. AIDS Care (2009) 1.11
Prevalence of HIV infection among inpatients and outpatients in Department of Veterans Affairs health care systems: implications for screening programs for HIV. Am J Public Health (2007) 1.10
Prevalence and correlates of unknown HIV infection among patients seeking care in a public hospital emergency department. Public Health Rep (2009) 1.10
Video as an effective method to deliver pretest information for rapid human immunodeficiency testing. Acad Emerg Med (2008) 1.10
Educational effectiveness of an HIV pretest video for adolescents: a randomized controlled trial. Pediatrics (2011) 1.03
Gender differences in HIV risk behaviors in an adult emergency department in New York City. J Urban Health (1999) 0.99
Demographic variations in HIV testing history among emergency department patients: implications for HIV screening in US emergency departments. J Med Screen (2009) 0.97
Patient risks, outcomes, and costs of voluntary HIV testing at five testing sites within a medical center. Public Health Rep (2008) 0.94
HCV among The Miriam Hospital and Rhode Island Hospital Adult ED Patients. R I Med J (2013) (2014) 0.83
Interrelationship of alcohol misuse, HIV sexual risk and HIV screening uptake among emergency department patients. BMC Emerg Med (2013) 0.83
Prevalence of Heavy Drinking and Risky Sexual Behaviors in Adult Emergency Department Patients. Alcohol Clin Exp Res (2015) 0.81
Estimation of the prevalence of undiagnosed and diagnosed HIV in an urban emergency department. PLoS One (2011) 0.78
Introducing routine HIV screening for patients on an internal medicine residency inpatient service: a quality improvement project. BMJ Qual Improv Rep (2016) 0.75
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med (1984) 6.11
Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med (1977) 5.86
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol (1997) 5.76
Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72
Transmission of the human immunodeficiency virus. N Engl J Med (1987) 4.17
Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med (1983) 3.67
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med (2000) 3.15
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. Arch Intern Med (1985) 2.62
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis (2001) 2.51
Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41
Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med (1986) 2.40
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med (1992) 2.36
The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30
Survival differences in patients with AIDS. J Acquir Immune Defic Syndr (1991) 2.23
Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell (2001) 2.20
High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA (1992) 2.19
Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med (1979) 2.06
Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med (1993) 1.92
Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis (2001) 1.77
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis (1999) 1.69
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63
A prospective study of HIV disease progression in female and male drug users. AIDS (1999) 1.54
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study. Obstet Gynecol (2001) 1.51
Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med (1996) 1.47
Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol (1987) 1.47
Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1992) 1.40
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health (1995) 1.40
High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol (1991) 1.39
Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1990) 1.36
The underrecognition of HIV infection in women in an inner-city emergency room. Am J Public Health (1993) 1.35
Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection. Antimicrob Agents Chemother (1979) 1.30
The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med (1985) 1.29
Adolescent heterosexual experience: a new typology. J Adolesc Health (1997) 1.28
Cancer incidence in women with or at risk for HIV. Int J Cancer (2001) 1.23
Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol (1987) 1.23
Infectious diarrhea in patients with AIDS. Dig Dis Sci (1988) 1.22
A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infect Dis Obstet Gynecol (2001) 1.17
Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis. J Clin Microbiol (1997) 1.16
Biological action of inosine analogs in Leishmania and Trypanosoma spp. Antimicrob Agents Chemother (1984) 1.11
A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis (1997) 1.11
High testicular salvage rate in torsion of the spermatic cord. J Urol (1982) 1.11
Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr (2001) 1.10
Community-acquired opportunistic infections and defective cellular immunity in heterosexual drug abusers and homosexual men. Am J Med (1983) 1.10
Reactions of cytosine derivatives with acidic buffer solutions. II. Studies on transamination, deamination, and deuterium exchange. Biochemistry (1967) 1.08
Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med (2001) 1.06
Lack of association of Streptococcus bovis with noncolonic gastrointestinal carcinoma. Am J Gastroenterol (1987) 1.06
Nucleosides. 73. Ribosyl analogs of chloramphenicol. J Org Chem (1971) 1.05
Pneumocystis carinii pneumonia therapy with 9-deazainosine in rats. Diagn Microbiol Infect Dis (1987) 1.05
Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer (1994) 1.03
An effective hospital-based pneumococcal immunization program. Arch Intern Med (1986) 1.02
A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY. Am J Public Health (1996) 1.02
Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol (2001) 1.01
A prospective study of tuberculosis and HIV disease progression. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.01
Mycobacterium gordonae in the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.00
Activity of inosine analogs against Pneumocystis carinii in culture. Antimicrob Agents Chemother (1986) 1.00
Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) Group. Clin Infect Dis (1998) 1.00
Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J Leukoc Biol (2006) 0.99
Gender differences in HIV risk behaviors in an adult emergency department in New York City. J Urban Health (1999) 0.99
Oropharyngeal Candida colonization and human immunodeficiency virus type 1 infection. J Infect Dis (2000) 0.98
Abnormal glucose metabolism among older men with or at risk of HIV infection. HIV Med (2006) 0.97
The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2001) 0.97
Carcinoma of the colon 2 years after endocarditis due to Streptococcus bovis. Am J Gastroenterol (1983) 0.96
Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol (1991) 0.96
Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis (2003) 0.96
Fertility in persons with epilepsy: 1935-1974. Epilepsia (1987) 0.96
Defective in vitro T cell colony formation in the acquired immunodeficiency syndrome. J Immunol (1985) 0.95
Additional evidence for lack of transmission of HIV infection by close interpersonal (casual) contact. AIDS (1990) 0.95
Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats. Antimicrob Agents Chemother (1994) 0.95
Nucleosides. 78. Synthesis of some 6-substituted uracils and uridines by the Wittig reaction. J Org Chem (1972) 0.95
Behavioral risks for HIV infection associated with HIV-testing decisions. AIDS Educ Prev (1996) 0.94
Acquired immunodeficiency syndrome. Ophthalmic manifestations in ambulatory patients. Ophthalmology (1983) 0.94
Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis. AIDS (1999) 0.93
Nucleosides. 123. Synthesis of antiviral nucleosides: 5-substituted 1-(2-deoxy-2-halogeno-beta-D-arabinofuranosyl)cytosines and -uracils. Some structure-activity relationships. J Med Chem (1983) 0.93
Rates of and factors associated with self-reported prior HIV testing among adult medical patients in an inner city emergency department in the Bronx, New York City. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.92
Mycobacterium tuberculosis bacteremia in the acquired immunodeficiency syndrome. JAMA (1986) 0.91
Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases. Med Oncol (1999) 0.90
Body image in older men with or at-risk for HIV infection. AIDS Care (2007) 0.90
Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. AIDS Patient Care STDS (2001) 0.89
Body image in middle-aged HIV-infected and uninfected women. AIDS Care (2006) 0.89
Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) Group. Am J Med (1998) 0.89
Regional variation in CCR5-Delta32 gene distribution among women from the US HIV Epidemiology Research Study (HERS). Genes Immun (2002) 0.88
Haemophilus parainfluenzae septic arthritis in an adult. JAMA (1981) 0.88
Effect of HIV infection on menstrual cycle length. J Acquir Immune Defic Syndr (2000) 0.87
Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1989) 0.87
Major aphthous-like ulcers in patients with AIDS. Oral Surg Oral Med Oral Pathol (1991) 0.86
Synergism between 9-deazainosine and DL-alpha-difluoromethylornithine in treatment of experimental African trypanosomiasis. Antimicrob Agents Chemother (1987) 0.86
Defective T-cell colony formation and IL-2 receptor expression at all stages of HIV infection. Clin Exp Immunol (1988) 0.86
Stress, coping, and attitudes toward HIV treatment in injecting drug users: a qualitative study. AIDS Educ Prev (1995) 0.86
Viral sensing at the blood-brain barrier: new roles for innate immunity at the CNS vasculature. Clin Pharmacol Ther (2015) 0.85
Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome. Obstet Gynecol (1993) 0.85
Activity of purine analogs against Leishmania donovani in vivo. Antimicrob Agents Chemother (1987) 0.85
The recovery of Mycobacterium avium complex and Mycobacterium tuberculosis from blood specimens of AIDS patients using the nonradiometric BACTEC NR 660 medium. Am J Clin Pathol (1990) 0.85
Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug users. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.85